AMSBIO Lipidure®-Coat low adhesion plates and dishes are shown in cited research to be one of the most effective tools for state-of-the-art 3D spheroid cell culture. These new plates and dishes are available in 384-well format optimised for drug screening or other high throughput applications. Spheroid cell culture is based on the spontaneous formation of […]
Xuri™ MSC Medium is a versatile and reliable cell culture product that enables the safe and efficient expansion of human mesenchymal stem cells (hMSC) without the use of animal derived components or undefined serum. It can be used to culture hMSC from a range of sources, including bone marrow, umbilical cord, or adipose tissue. Compared […]
HOLLISTON, Mass.– Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, has named Ronald Aplin to Vice President Global Operations and Quality, effective immediately. This is a newly created position. Mr. Aplin has more than 25 years experience in operations and supply chain […]
Promethera® Biosciences, a company that develops innovative therapies for the treatment of liver diseases, today announces a collaboration with EMD Millipore to develop an improved ready-to-use microfluidic perfusion liver assay. This new product is designed to perform more robust studies in pre-clinical toxicity and drug metabolism. Early availability of reliable human liver-based assays is critical […]
Paris (France), -– IMSTAR is pleased to announce the recent collaboration with Japan Tobacco Inc. (JTI) following the set-up of its Pathfinder™ Screentox Auto Micronucleus Image Cytometer System for in vitro/in vivo genetic toxicology studies at JTI’s Research Center near Tokyo. Japan Tobacco Inc. (JTI) will apply Pathfinder™ Screentox technology for automated scoring of micronucleus […]
ALAMEDA, Calif.– BioTime, Inc. (NYSE MKT: BTX) today announced it has sold 70,000 shares of a newly authorized Series A Convertible Preferred Stock for $3.5 million. The Series A Preferred Stock carries a cumulative annual 3% preferred dividend or $1.50 per share, in preference to BioTime common shares. Each share of Series A Preferred Stock […]
Stevenage, UK –Plasticell, the biotechnology company specializing in stem cell differentiation, has today announced that it has signed a collaboration agreement with JCR Pharmaceuticals Co., Ltd. of Ashiya, Hyogo Pref., Japan, to discover custom stem cell culture media using its award-winning combinatorial stem cell technology, CombiCult®. Under the terms of the agreement, Plasticell will use […]
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the current cancer research project of Dr Florian T. Ludwig at the Institute of Physiology II, University Hospital Münster, who uses a CellHesion® 200 to measure the adhesive forces between tumor cells. The Institute of Physiology II […]
Strasbourg, France –– Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology, announces today that it has granted two agencies of the United States National Institutes of Health (“NIH”) a non-exclusive, research license to use Polyethylenimine (PEI) for in vitro transfection applications. The two agencies are the National Institute of Allergy […]
SYDNEY — Australian stem cell company Genea Biocells is now the world’s largest provider of human embryonic stem cell (hESC) lines on the USA National Institutes of Health (NIH) Stem Cell Registry. The approval of 52 of Genea’s hESC lines provides academic and commercial researchers with innovative cellular tools to drive the discovery of new […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
